Cargando…
Bioinformatic identification of previously unrecognized amyloidogenic proteins
Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intri...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108986/ https://www.ncbi.nlm.nih.gov/pubmed/35405097 http://dx.doi.org/10.1016/j.jbc.2022.101920 |
_version_ | 1784708821796519936 |
---|---|
author | Rosenberg, Gregory M. Murray, Kevin A. Salwinski, Lukasz Hughes, Michael P. Abskharon, Romany Eisenberg, David S. |
author_facet | Rosenberg, Gregory M. Murray, Kevin A. Salwinski, Lukasz Hughes, Michael P. Abskharon, Romany Eisenberg, David S. |
author_sort | Rosenberg, Gregory M. |
collection | PubMed |
description | Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intrinsically disordered and function in self-association. The question therefore arises whether a search for pathogenic mutations in LCDs of the human proteome can lead to identification of other proteins associated with amyloid disease. Here, we take a computational approach to identify documented pathogenic mutations within LCDs that may favor amyloid formation. Using this approach, we identify numerous known amyloidogenic mutations, including several such mutations within proteins previously unidentified as amyloidogenic. Among the latter group, we focus on two mutations within the TRK-fused gene protein (TFG), known to play roles in protein secretion and innate immunity, which are associated with two different peripheral neuropathies. We show that both mutations increase the propensity of TFG to form amyloid fibrils. We therefore conclude that TFG is a novel amyloid protein and propose that the diseases associated with its mutant forms may be amyloidoses. |
format | Online Article Text |
id | pubmed-9108986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-91089862022-05-20 Bioinformatic identification of previously unrecognized amyloidogenic proteins Rosenberg, Gregory M. Murray, Kevin A. Salwinski, Lukasz Hughes, Michael P. Abskharon, Romany Eisenberg, David S. J Biol Chem Research Article Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intrinsically disordered and function in self-association. The question therefore arises whether a search for pathogenic mutations in LCDs of the human proteome can lead to identification of other proteins associated with amyloid disease. Here, we take a computational approach to identify documented pathogenic mutations within LCDs that may favor amyloid formation. Using this approach, we identify numerous known amyloidogenic mutations, including several such mutations within proteins previously unidentified as amyloidogenic. Among the latter group, we focus on two mutations within the TRK-fused gene protein (TFG), known to play roles in protein secretion and innate immunity, which are associated with two different peripheral neuropathies. We show that both mutations increase the propensity of TFG to form amyloid fibrils. We therefore conclude that TFG is a novel amyloid protein and propose that the diseases associated with its mutant forms may be amyloidoses. American Society for Biochemistry and Molecular Biology 2022-04-09 /pmc/articles/PMC9108986/ /pubmed/35405097 http://dx.doi.org/10.1016/j.jbc.2022.101920 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Rosenberg, Gregory M. Murray, Kevin A. Salwinski, Lukasz Hughes, Michael P. Abskharon, Romany Eisenberg, David S. Bioinformatic identification of previously unrecognized amyloidogenic proteins |
title | Bioinformatic identification of previously unrecognized amyloidogenic proteins |
title_full | Bioinformatic identification of previously unrecognized amyloidogenic proteins |
title_fullStr | Bioinformatic identification of previously unrecognized amyloidogenic proteins |
title_full_unstemmed | Bioinformatic identification of previously unrecognized amyloidogenic proteins |
title_short | Bioinformatic identification of previously unrecognized amyloidogenic proteins |
title_sort | bioinformatic identification of previously unrecognized amyloidogenic proteins |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108986/ https://www.ncbi.nlm.nih.gov/pubmed/35405097 http://dx.doi.org/10.1016/j.jbc.2022.101920 |
work_keys_str_mv | AT rosenberggregorym bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins AT murraykevina bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins AT salwinskilukasz bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins AT hughesmichaelp bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins AT abskharonromany bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins AT eisenbergdavids bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins |